- GILD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $1.2 billion.
- GILD has traded 202,865 shares today.
- GILD is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in GILD with the Ticky from Trade-Ideas. See the FREE profile for GILD NOW at Trade-Ideas More details on GILD: Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. The stock currently has a dividend yield of 1.5%. GILD has a PE ratio of 13. Currently there are 13 analysts that rate Gilead a buy, 1 analyst rates it a sell, and 2 rate it a hold. The average volume for Gilead has been 11.2 million shares per day over the past 30 days. Gilead has a market cap of $167.1 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.87 and a short float of 4.1% with 4.46 days to cover. Shares are up 21.7% year-to-date as of the close of trading on Tuesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.